Related Experiment Video For Crohn’s disease
Updated: Feb 17, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Integrated Multiomics Elucidates Molecular Mechanisms of Bisphenol A in Exacerbating Crohn's Disease
Liangliang Dai1,2, Chenjie Qiu3
1Department of Urology, Wujin Hospital Affiliated With Jiangsu University, Changzhou, 213004, China, ujs.edu.cn.
Background:
Bisphenol A (BPA), a widespread environmental endocrine-disrupting chemical, has been associated with the development and progression of Crohn's disease (CD), yet its precise molecular mechanisms remain unclear. We aimed to systematically elucidate the potential molecular mechanisms by which BPA exacerbates CD and to identify key biomarkers and therapeutic targets.
Methods:
BPA-related targets and CD transcriptomic datasets (GSE36807, GSE75214, and GSE95095) were retrieved from public databases. Overlapping genes were identified and subjected to functional enrichment and protein-protein interaction (PPI) network analysis. Multiple machine learning algorithms were employed to screen for core genes, and molecular docking was used to validate the binding affinity between BPA and core proteins. Immune infiltration analysis and regulatory network construction were performed to explore the roles of core genes in the immune microenvironment and post-translational regulation.
Results:
A total of 65 overlapping genes between BPA and CD were identified, primarily enriched in pathways related to inflammation, apoptosis, and immune regulation. Machine learning screened five core genes (HGF, IL1R1, MMP1, MMP2, and NTRK2), which demonstrated strong diagnostic performance in independent datasets. Molecular docking revealed strong binding affinity between BPA and these proteins, with the lowest binding energy observed for MMP2 (-8.4 kcal/mol). Immune infiltration analysis indicated significant correlations between core genes and immune cell subsets such as Tr1, Th17, and Tfh cells. Regulatory network analysis identified key transcription factors (e.g., STAT3) and E3 ubiquitin ligases (e.g., SYVN1) involved in gene regulation.
Conclusion:
BPA may exacerbate CD progression by dysregulating core genes, such as HGF, IL1R1, MMP1, MMP2, and NTRK2, thereby disrupting inflammatory balance, extracellular matrix remodeling, and immune homeostasis.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

